New weekly pack could cut costs and fight child malnutrition

NCT ID NCT07540793

Not yet recruiting Prevention Sponsor: University of California, San Francisco Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study in Ethiopia tests whether a new 7-day package of a nutritional supplement (SQ-LNS) works as well as the usual daily packets for preventing malnutrition in children aged 6-24 months. Researchers will compare how well families stick to using each package type over 8 weeks. The goal is to see if the new design is acceptable, safe, and leads to similar or better use, potentially lowering costs and improving distribution.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Small Quantity Lipid-based Nutrient Supplements (SQ-LNS)
What this could lead to: If successful, this could lead to cheaper, easier distribution of a supplement that helps prevent malnutrition in young children.
What could go wrong: This is a small, early-stage study focused on packaging and adherence, not on health outcomes. The new packaging may not be used as intended or could have safety issues.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for MALNUTRITION, CHILD are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Child Nutrition Disorders nutritional disorder nutritional deficiency disease prevention target

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

MALNUTRITION, CHILD NUTRITION PREVENTION

Contacts and locations

Locations

Debre Berhan University

Debre Berhan, Ethiopia
Heidelberg University

Heidelberg, Germany
Research Institute of Tropical Medicine

Manila, Philippines

More trials for these conditions

Other studies related to the condition(s) this trial covers.